Polaris Venture Management Co. V, L.L.C.
Q2 2014 13F-HR Holdings
Net value change ($000)
+2,335
(1.9%)
New positions
1
Sold out positions
2
Turnover %
18.4%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q1 2014
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| CERULEAN PHARMA INC | 19,068 | NEW |
| BIND THERAPEUTICS INC | 2,462 | 10.2% |
| GENOCEA BIOSCIENCES, INC. | 1,192 | 3.1% |
Top Reduces (Value $000, Stocks/ETFs)
| FATE | -8,483 | -35.2% |
| TREVENA INC | -8,424 | -28.1% |
| TWTR | -3,446 | -100.0% |
| *TRULIA INC | -34 | -100.0% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|